Advantages of standardizing vaccine and antibody nomenclature.
Grabenstein
John D
JD
Scientific Affairs, Merck Vaccines & Infectious Diseases, West Point, PA, USA. john_grabenstein@merck.com
D000906:Antibodies / Q000145:classification*; D017408:Guidelines as Topic; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control; D009626:Terminology as Topic; D014612:Vaccines / Q000145:classification*
D000906:Antibodies; D014612:Vaccines